Publicaciones
-
Butjosa A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.
Development and validation of the Questionnaire of Stressful Life Events (QSLE).
JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Nº de citas: 8
-
Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M and PEPs Group.
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
SCHIZOPHRENIA RESEARCH . 189: 84-90. Nº de citas: 33
-
Esther Pousa Tomas, Ochoa S, Cobo JV, María de Lourdes Nieto García, Usall J, González B, Garcia-Ribera C, Pérez-Solà V, Ruiz A and Insight Barcelona Research Group.
A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors
SCHIZOPHRENIA RESEARCH . 189: 61-68. Nº de citas: 25
-
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de citas: 3
-
Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J and Group TP.
Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.
JOURNAL OF CLINICAL PSYCHIATRY . 78(9): 1414-1422. Nº de citas: 21
-
Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A and PEPs Group.
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(7): 647-656. Nº de citas: 7
-
Massons C, Lopez-Morinigo JD, Esther Pousa Tomas, Ruiz A, Ochoa S, Usall J, María de Lourdes Nieto García, Cobo J, David AS and Dutta R.
Insight and suicidality in psychosis: A cross-sectional study.
PSYCHIATRY RESEARCH . 252: 147-153. Nº de citas: 28
-
Butjosa A, Gómez-Benito J, Huerta-Ramos ME, del Cacho N, Barajas A, Baños I, Usall J, Dolz M, Sánchez Fernández B, Carlson J, Haro JM, GENIPE group and Ochoa S.
Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis.
PSYCHIATRY RESEARCH . 245: 108-115. Nº de citas: 14
-
Labad J, Martorell L, Huerta-Ramos ME, Cobo J, Vilella E, Rubio E, Garcia-Pares G, Creus M, Nuñez C, Ortega L, Miquel E, RALOPSYCAT Group and Usall J.
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
EUROPEAN NEUROPSYCHOPHARMACOLOGY . 26(10): 1683-1689. Nº de citas: 18
-
Rubio E, del Cacho N, Saenz-Navarrete G, Arranz B, Cambra RM, Cuadras-Palleja D, Rodante D, Fehér C, Roca M, Barneda V, Usall J and PROLACT Group.
How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 36(5): 422-428. Nº de citas: 21